Nathan Coyle
Fortune : 110 $ au 31/07/2026
Fortune : 110 $ au 31/07/2026
Nathan Coyle is currently Controller at Quantum BioPharma Ltd. since 2024.
Formerly, Controller at Chem-Ecol Ltd. from 2013 to 2020.
Educated at Brock University with an undergraduate degree.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/09/2025 | 38 ( 0 % ) | 110 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| QUANTUM BIOPHARMA LTD. | Comptroller/Controller/Auditor | 30/08/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Chem-Ecol Ltd.
Chem-Ecol Ltd. Industrial SpecialtiesProcess Industries Manufactures industrial oils and lubricants | Comptroller/Controller/Auditor | 01/01/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Brock University
Brock University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chem-Ecol Ltd.
Chem-Ecol Ltd. Industrial SpecialtiesProcess Industries Manufactures industrial oils and lubricants | Process Industries |
FSD Pharma, Inc.
FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national